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Patients with Danon disease may suffer from severe cardiomyopathy, skeletal muscle dysfunction as well
as varying degrees of mental retardation, in which the primary deﬁciency of lysosomal membrane-
associated protein-2 (LAMP2) is considerably associated. Owing to the scarcity of human neurons, the
pathological role of LAMP2 deﬁciency in neural injury of humans remains largely elusive. However, the
application of induced pluripotent stem cells (iPSCs) may shed light on overcoming such scarcity.
In this study, we obtained iPSCs derived from a patient carrying a mutated LAMP2 gene that is as-
sociated with Danon disease. By differentiating such LAMP2-deﬁcient iPSCs into cerebral cortical neurons
and with the aid of various biochemical assays, we demonstrated that the LAMP2-deﬁcient neurons are
more susceptible to mild oxidative stress-induced injury.
The data fromMTT assay and apoptotic analysis demonstrated that there was no notable difference in
cellular viability between the normal and LAMP2-deﬁcient neurons under non-stressed condition. When
exposed to mild oxidative stress (10 μM H2O2), the LAMP2-deﬁcient neurons exhibited a signiﬁcant
increase in apoptosis. Surprisingly, we did not observe any aberrant accumulation of autophagic mate-
rials in the LAMP2-deﬁcient neurons under such stress condition.
Our results from cellular fractionation and inhibitor blockade experiments further revealed that
oxidative stress-induced apoptosis in the LAMP2-deﬁcient cortical neurons was caused by increased
abundance of cytosolic cathepsin L. These results suggest the involvement of lysosomal membrane
permeabilization in the LAMP2 deﬁciency associated neural injury.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Lysosomes are organelles responsible for the degradation of
obsolete cellular constituents and cellular materials [1,2], and exist
in virtually all eukaryotic cells. These organelles have long been
regarded as merely trash cans; however, some latest reports de-
monstrated that they are involved in many vital cellular processes,
including autophagy, plasma membrane repair and mediation of
cell death [3,4].B.V. This is an open access article u
a Shing Faculty of Medicine,
ding, L5-03, Laboratory Block,
gion.
).Structurally, lysosomes are conﬁned by individual phospholi-
pid-bilayers whilst the lysosomal membrane contains speciﬁc sets
of glycoproteins. The luminal domains of these proteins are usually
highly glycosylated, so that they protect the lysosomal membranes
against autolysis. Such unique membrane structures are important
because injury of the lysosomal membrane may trigger the release
of hydrolytic enzymes into the cytosol thus leading to apoptosis
[5–7] or necrotic cell death [8].
To date, more than 20 lysosomal membrane proteins have been
identiﬁed. Among them, lysosomal membrane-associated protein-
1 and -2 (LAMP1 and LAMP2) are the most abundant. The func-
tional roles of these two proteins are incompletely understood;
yet, data from clinical and animal studies have suggested a direct
association between LAMP2 and autophagy [9,10]. Accordingly tonder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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disease, which is a multisystem disorder associated with high
morbidity and early mortality [11]. Aberrant accumulation of au-
tophagic vacuoles had been observed in tissue samples of patients
with Danon disease and LAMP2-deﬁcient mice [4,8,12,13] sug-
gesting that autophagy dysfunction is the plausible cause of cel-
lular abnormality. To date, a number of reports acquainted the
impact of LAMP2 deﬁciency on the dysfunction of human cardio-
myocytes; however, investigation of such deﬁciency on neural
defects is rather limited. We believe the scarcity of source and
difﬁculties in cultural maintenance largely restrained the studies
of pathological signiﬁcance of LAMP2 deﬁciency on human
neurons.
With the latest development of the induced pluripotent stem
cell (iPSC) technology, patient speciﬁc-iPSCs can now be efﬁciently
differentiated into various cell types such as cardiomyocytes and
cortical neurons [14,15]. To this end, such technology provides an
authentic human cell-based platform for modeling various in-
heritable disorders. Recently, we have identiﬁed from members of
a Chinese family a novel LAMP2 (c.183_184insA) mutation that is
associated with severe cardiomyopathy. Although cardiomyopathy
is the leading cause of death in patients with primary LAMP2
deﬁciency [13], mental retardation is often observed in many of
these patients [16–18]. As such, the iPSCs generated from the pa-
tients with LAMP2 mutation represent a powerful tool for evalu-
ating the pathophysiological mechanisms of LAMP2-deﬁciency
and the associated multiple system disorders, particularly related
to the c.183_184insA mutation of the LAMP2 gene.
With the advent of iPSC technology, we and many other re-
search groups are determined to investigate the association be-
tween LAMP2 deﬁciency and cardiac disorders, as well as the
pathophysiological mechanism underlying LAMP2 mutations and
neural dysfunction. In the present study, we successfully generated
LAMP2-deﬁcient iPSCs from a male patient and differentiated
them into cerebral cortical neurons for disease modeling. This
study is the ﬁrst to report that the LAMP2-deﬁcient human neu-
rons are more susceptible to oxidative stress-induced apoptotic
cell death and such apoptotic mechanism was associated with an
increased lysosomal membrane permeabilization (LMP).2. Materials and methods
2.1. Patient
The patient sample of this study has been described previously
[13]. In brief, the cardiac biopsies were obtained from a 17-year-
old male, designated Patient II-1, who showed left ventricular
hypertrophic pattern and diffused deep symmetrical T inversion.
He was diagnosed with Danon disease rooted from the lack of
LAMP2 protein production. From his cardiac biopsies, an insertion
of “A” residue between the 183th and 184th position of the LAMP2
gene was identiﬁed by means of the detailed genomic DNA se-
quencing analysis. For this reason, this mutation will be denoted as
LAMP2-c.183_184insA in this article. The sequencing analysis in-
dicated that this mutation created multiple stop codons down-
stream of the affected region. As a result, any polypeptides
translated from this allele were predicted to be extremely short.
2.2. Generation of LAMP2-deﬁcient iPSCs
The protocol for the procurement of human tissue for use in
our reprogramming experiments of this study was approved by
the Institutional Review Board of Queen Mary Hospital, Hong
Kong, and was registered at the Clinical Trial Center (HKCTR-725),
The University of Hong Kong, (http://www.hkclinicaltrials.com).Written informed consents had been obtained from all partici-
pants. The detailed procedures of iPSCs generation from patient
biopsy have been described previously [14,19]. In Brief, skin
biopsies were performed, from which dermal ﬁbroblasts were
collected and expanded accordingly in Dulbecco's Modiﬁed Eagle
Medium (DMEM, Gibco) supplemented with 10% fetal bovine
serum (FBS, Gibco). Skin ﬁbroblasts were cultured in 6-well plates
at a density of 1105 cells/well, and infected with a cocktail of
retrovirus packaged with Yamanaka's 4 factors, human Sox2, Klf4,
Oct4 and c-Myc [20]. Putative iPSCs-like clones were selected
manually and expanded with feeder-free systems in StemPro hESC
medium (Gibco) in Geltrex-coated plates. Authenticity of iPSCs
was determined by means of standard characterization methods
such as pluripotency marker expression analysis, Nanog promoter
analysis and in vivo teratoma formation (for details, please refer to
Supplementary Fig. 1). To minimize clone-to-clone variation, data
collected in the present study were derived from more than 3 in-
dividual clones of the patient derived iPSCs. In addition, the well
characterized iPSC line KS1, [19] which was generated from a
healthy male individual, was used as the control in the present
study.
2.3. Neural induction
The differentiation of iPSCs into cerebral cortical neurons was
performed according to a published protocol [15] with modiﬁca-
tions. In brief, iPSC colonies were dissociated into single cells using
accutase and cultured in Matrigel-coated 12-well plates at a den-
sity of 7.5105 cells/well. These dissociated cells were maintained
in TeSR™-E8™ medium (STEMCELL Technologies, USA) and sup-
plemented with 10 mM Y-27632 for an enhancement of cell via-
bility. When cells reached 100% conﬂuence, neural differentiation
was induced by switching to a neural induction medium [DMEM/
F-12 medium (Gibco) supplemented with noggin (500 ng/mL,
Sigma-Aldrich), SB 431542 (10 mM, Sigma-Aldrich), 0.5 X N-2
supplement (Gibco), 2-mercaptoethanol (50 mM, Gibco), 0.5 X B-27
supplement (Gibco) and insulin (5 mg/mL, Sigma-Aldrich)]. Neural
induction medium was replaced every day for 14 days until the
formation of uniform neuroepithelial sheets. The neuroepithelial
sheet was passed onto Matrigel-coated 6-well plates and cultured
in neural induction medium supplemented with 10 mM Y-27632
for 1 day. Thereafter, the induced cells were maintained in neural
maintenance medium (neural induction medium without noggin
and SB 431542). Once the neural rosettes became observable
(around 17 days after induction), the culturing medium was sup-
plemented with ﬁbroblast growth factor-2 (FGF2, 20 ng/mL) for
neural expansion. The differentiated neurons were ready for ex-
periments after 2–3 passages.
2.4. Cardiac differentiation
Differentiations of iPSCs into cardiomyocytes were performed
using the commercial PSC-Cardiomyocyte Differentiation Kit
(Gibco). In brief, monolayers of iPSCs were prepared following the
methods previously described in Section 2.3. At 70% conﬂuency,
the spent medium was replaced with Cardiomyocyte Differentia-
tion Medium A provided in the differentiation kit and cultured for
2 days. Next, spent medium was replaced with Cardiomyocyte
Differentiation Medium B and the differentiating cells were cul-
tured for additional 2 days. Subsequently, dead cells were washed
out with 1X PBS and the differentiating cells were kept culturing
in Cardiomyocyte Maintenance Medium provided in the differ-
entiation kit until the appearance of beating cardiomyocytes
(about 14 days after the initiation of cardiac differentiation). In the
meantime, spent medium was refreshed every 2–3 days.
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To induce oxidative stress, iPSCs-derived neurons were treated
with different concentrations of hydrogen peroxide (H2O2, Sigma-
Aldrich). Unless stated speciﬁcally, the time for H2O2 treatment
was 24 h. When necessary, cathepsin L speciﬁc inhibitor was ad-
ded as an anti-oxidative stress agent.
2.6. Antibodies
Monoclonal antibodies speciﬁc to Nanog (09-0020), Oct-4 (09-
0023). SSEA-4 (09-0006) and TRA-1-60 (09-0010) were purchased
from Stemgent. Monoclonal antibodies speciﬁc to LAMP1 (14-
1079) and LAMP2 (14-1078) were purchased from eBioscience.
Monoclonal antibody speciﬁc to cathepsin L (C4618) was pur-
chased from Sigma-Aldrich. Monoclonal antibodies speciﬁc to
MAP2 (8707) were purchased from cell signaling technology.
Polyclonal antibody speciﬁc to N-terminal of LAMP2 (sc-5571) and
monoclonal antibody speciﬁc to β-ACTIN (sc-47778) were pur-
chased from Santa Cruz biotechnology.
2.7. Cell lysis and Western blot analysis
iPSCs-derived neurons were harvested by scraping and cell
pellets were collected by centrifugation. For total protein isolation,
cells were lysed with RIPA buffer (Sigma-Aldrich) supplemented
with protease inhibitor cocktail (Sigma-Aldrich). Cell debris was
removed by centrifugation and the supernatant was saved. The
cytosolic fraction, when needed, was isolated using the subcellular
protein fractionation Kit (Thermo Scientiﬁc) following the manu-
facturer's instruction. For Western blot analysis, 25–40 mg of total
or cytosolic protein samples were resolved on 4–12% Bolts Bis-Tris
Plus gels (Invitrogen, USA) and transferred onto PVDF membranes
using the iBlots system (Invitrogen). The membranes were then
blocked with Tris-buffered saline (TBS) containing 5% non-fat dry
milk and 0.05% Tween-20 for 1 h at room temperature. After-
wards, membranes were incubated with appropriate primary an-
tibodies at 4 °C for 16 h. Unbound antibodies were removed by
three washes with washing buffer (TBS containing 0.05% Tween-
20) followed by the incubation of HRP-conjugated secondary an-
tibodies. Unbound secondary antibodies were removed by three
washes with washing buffer and the immunoreactive proteins
were detected using the Amersham ECL Prime Western Blotting
Detection Reagent (GE Healthcare Life Science).
2.8. Immunoﬂuorescence staining
Immunoﬂuorescence staining was performed according to the
method described previously [21]. In brief, iPSCs-derived neurons
were ﬁxed with 2% paraformaldehyde for 10 min at room tem-
perature, washed with phosphate-buffered saline (PBS) and per-
meabilized with PBS containing 0.05% Triton-X 100 (PBS-T) for
10 minutes at room temperature. Cells were then incubated with
appropriate primary antibodies at 4 °C overnight. Unbound anti-
bodies were removed by 3 washes with PBS and neurons were
incubated with alexa ﬂuor-conjugated secondary antibodies (Alexa
488 or Alexa 647) for 30 min. The samples were mounted with
ProLongs Gold Antifade Mountant with DAPI (life technology) and
examined under the Olympus ﬂuorescence microscope.
2.9. Cell viability assay
The iPSCs-derived neurons were ﬁrstly seeded in 96-well plates
with 200 μl of neural maintenance medium at a density of
1104 cells/well at 37 °C for 48 h to allow growth and even at-
tachment. Thereafter, the cells were exposed to differentconcentrations of H2O2 in the presence or absence of cathepsin-L
inhibitor for 24 h. Afterward, 3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyltetrazolium bromide (MTT) solution (10 μl) was added into
each well. After the 4-h incubation at 37 °C, the wells were drained
and DMSO solution (100 μl) was added into each well to dissolve
the formazan. The absorbance at wavelength 540 nm was mea-
sured using a microplate reader.
2.10. TUNEL assay
The apoptotic status of the iPSC-derived neurons was evaluated
using the APO-BrdU™ TUNEL Assay Kit (Life tech., USA). Experi-
ments were performed following the manufacturer's instruction,
in brief, the iPSC-derived neurons were dissociated with accuses
and collected by centrifugation. Cell pellets were re-suspended in
PBS and ﬁxed with 4% paraformaldehyde on ice for 15 min. Par-
aformaldehyde was removed by centrifuging and the cell pellets
were washed with PBS twice. Afterwards, cell pellets were re-
suspended in PBS and ice-cold 70% ethanol was added to each
sample. The cell suspension was then incubated overnight at
20 °C. The damaged DNA in the samples were labeled with DNA-
labeling solution (10 mL reaction buffer, 0.75 ml TdT enzyme, 8.0 ml
BrdUTP and 3.75 ml distilled water) and incubated at 37 °C for 1 h.
After incubation, the samples were washed twice with rinse buffer.
Then, washed samples were incubated with Alexa Fluor-488-la-
beled anti-BrdU antibody solution at room temperature for
30 min. The percentages of apoptotic cells were determined by
ﬂow cytometry.
2.11. Caspase-3/7 activity assay
The percentage of cells containing active caspase-3/7 was
evaluated using the CellEvents Caspase-3/7 green detection re-
agent (Invitrogen). Experiments were performed according to the
manufacturer's instruction. In brief, iPSC-derived neurons were
cultured on glass coverslips and treated with H2O2 at 37 °C for
24 h. Cathepsin L-inhibitor was used as a positive control. There-
after, the detection reagent was applied to each sample at the
concentration of 2 drops/1 ml medium. The cells were then in-
cubated with the detection reagent at 37 °C for 30 min. The sam-
ples were then examined under a ﬂuorescence microscope of a live
cell imaging system (name of the microscope). When needed, the
cells were ﬁxed with paraformaldehyde for an additional im-
munostaining analysis.
2.12. Periodic Acid-Schiff (PAS) staining
The intracellular accumulation of glycogen was evaluated using
the Periodic Acid-Schiff (PAS) staining kit (Sigma-Aldrich) follow-
ing the manufacturer's instruction. In Brief, iPSC-derived neurons
were cultured on gelatin-coated glass coverslips, ﬁxed with 1%
paraformaldehyde for 10 min and equilibrated in PBS prior to the
staining procedures. To start the staining, ﬁxed cells were im-
mersed in periodic acid solution for 5 min at room temperature.
The cells were then rinsed 5 times with distilled water and im-
mersed in Schiff's reagent for 15 min at room temperature. Reac-
tion was stopped by rinsing the cells in running tap water for
5 min. After that, slides were counterstained with hematoxylin
solution and examined under a light microscope.
2.13. Acridine orange staining
Acridine orange was purchased from Thermo Scientiﬁc, and the
staining procedure was performed following the instructions
provided by the manufacturer. In brief, cells of interest were cul-
tured in confocal dishes. At conﬂuence of 40–60%, the cells were
Fig. 1. LAMP2-C.183_184insA mutation abolished the production of LAMP2 protein. (A) Pedigree information about members of a Hong Kong family carrying the Danon
disease associated LAMP2 mutations. (B) Detection of an insertion of A in the exon 3 of the LAMP2 gene by means of genomic DNA sequencing analysis. (C) Outline of the
predicted amino acid sequences of the normal and mutant LAMP2 polypeptides. The affected coding regions are highlighted in yellow whereas the stop codons are
highlighted in red. The red arrow indicates the start of the affected area in the mutant. (D) Western blot analysis using an antibody speciﬁc to the N-terminal of LAMP2. The
absence of LAMP2 protein production in the skin ﬁbroblasts derived from Patient II-1 was conﬁrmed. (E and F) The absence of LAMP2 protein production in the iPSCs-
generated from Patient II-1 was conﬁrmed by immunostaining and Western blot analysis.
C.-Y. Law et al. / Biochemistry and Biophysics Reports 5 (2016) 335–345338
Fig. 2. LAMP2-deﬁcient iPSCs-derived cortical neurons were more susceptible to apoptotic cell death induced with 10 mM H2O2. (A) Immunostaining (right panel) and
Western blot analysis (left panel) conﬁrmed that the cortical neurons derived from Danon disease patient-speciﬁc-iPSCs were deﬁcient in LAMP2 production. Scale bar:
20 mm. (B) MTT assay was used to evaluate the viability of the iPSCs-derived cortical neurons under different concentrations of H2O2. n¼4 for each group. ***: Po0.001
comparing to the non-treated group of the same cell line, ###: Po0.001 comparison between the groups receiving 10 mM H2O2 treatment. (C) Flow cytometric analysis of
the iPSCs-derived cortical neurons treated with 10 mM H2O2, the basal value obtained from the group receiving 0 mM H2O2 treatment was assigned as 0% apoptosis. n¼4 for
each group, ***: Po0.001. (D) The percentage of activated caspase-3/7 cells were evaluated with the CellEvent Caspase-3/7 Green Detection Reagent. Scale bar: 40 mm.
n¼1000 cells from 3-7 ﬁelds for each group, ***: Po0.001 comparing to the normal neurons treated with 0 mM H2O2, ###: Po0.001 comparing to the LAMP2-deﬁcient
neurons treated with 0 mM H2O2.
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ture medium) at 37 °C for 10 min. Acridine orange-stained cells
were washed 3 times with normal culture medium, and examined
using the Olympus ﬂuorescence microscope.
2.14. Statistical analysis
Continuous variables are expressed as mean7SEM. Statistical
comparisons between two groups were performed using Student's
t test. One-way ANOVA or two-way ANOVA analyses were used for
comparing more than 2 groups. For one-way ANOVA analysis,
Tukey post-hoc test was used to compare all pairs of columns. For
two-way ANOVA analysis, Bonferroni post-hoc tests were per-
formed to compare the replicated means. Calculations were per-
formed with the GraphPad Prism 5 (GraphPad). Po0.05 was
considered statistically signiﬁcant.3. Results
3.1. LAMP2-c.183_184insA mutation abolished LAMP2 production
Recently, we have reported a LAMP2 mutation associated Da-
non disease from members of a Hong Kong family suffered from
severe cardiomyopathy (Fig. 1A). This speciﬁc mutation involves a
single nucleotide (A) insertion at the coding sequence region of
exon 3 of the LAMP2 gene (Fig. 1B). Sequencing analysis indicated
that such insertion creates multiple stop codons downstream of
the affected region (Fig. 1C), as such, any polypeptides translated
from the affected alleles were estimated to be very short (about
8.6 kDa) and unlikely to be functional. To investigate the existence
of these short truncated proteins, total proteins extracted from the
skin ﬁbroblasts were examined by means of Western Blot analysis.
By using a polyclonal antibody speciﬁc for the N-terminal region of
the human LAMP2 protein, we observed that the majority of the
immunoreactive proteins detected from the wildtype LAMP2
samples (Fig. 1D) were about 120 kDa, or so-called the full-length
form. Our observation was in agreement with published reports of
other research groups [22–24] and the difference between the
observed size and the size deduced from the amino acid sequen-
cing is likely due to the glycosylation of the protein [22]. In ad-
dition, a trace amount of immunoreactive protein of about 60 kDa
was obtained from the LAMP2-deﬁcient samples. To address
whether this truncated protein was derived from alternative
LAMP2 transcript(s) or from differential glycosylation, further
studies will be desperately needed. On the other hand, we were
not able to detect any LAMP2-immunoreactive signal in the total
protein isolated from the biopsy of Patient II-1 even we increased
the loading amount of protein to 40 mg. Similar results were ob-
served from the patient's iPSCs, no immunoreactive LAMP2 pro-
tein were detected in immunostaining or Western blot analysis
(Fig. 1E and F). These observations were in line with our previous
report that no immunoreactive LAMP2 was detected in the cardiac
biopsy of the same patient [13]. Based on these observations, we
believe that any polypeptides translated from the mutant LAMP2
allele are highly susceptible to degradation and do not accumulate
within the cell. As such, in the following sections, the iPSCs and
the neurons derived from Patient II-1 were denoted as LAMP2-
defeicient iPSCs or LAMP2-deﬁcient neurons respectively.
3.2. LAMP2 expression was diminished in LAMP2-deﬁcient iPSCs-
derived cortical neurons
Mental retardation is often observed in patients with Danon
disease. To investigate the direct effect of LAMP2 deﬁciency on the
brain, we adopted the speciﬁc protocols to generate cerebralcortical neurons for better recapitulation of the diseased condition.
As shown in Supplementary Fig. 2, uniform neuroepithelial sheets
began to form about 2 weeks after the start of induction. In ap-
proximately 60 days, the iPSCs-derived neurons were ready for
experiments. At this stage, over 70% of the iPSCs were MAP2-po-
sitive in both control and LAMP2-deﬁcient neurons indicating that
the cells were efﬁciently differentiated into neurons (Supple-
mentary Fig. 2). By means of immunostaining and Western Blot
analysis, we examined the LAMP2 protein levels in those iPSCs-
derived neurons. As showed in Fig. 2A, in the control groups, most
LAMP2 proteins were primarily distributed around the perinuclear
and cell body regions, though the abundance of LAMP2 in the axon
regions was not obvious. On the contrary, no LAMP2 signal was
detected in the LAMP2-deﬁcient neurons. Similar results were
observed in our Western Blot analysis (Fig. 2A, right panel).
3.3. LAMP2-deﬁcient neurons were more susceptible to oxidative
stress-induced apoptosis
In order to compare the viabilities of the cortical neurons de-
rived from control iPSCs and LAMP2-deﬁcient iPSCs, MTT assays
were performed. As shown in Fig. 2B, under non-stress condition,
there was no signiﬁcant difference in cell viability between the
two groups. However, when subjected to mild oxidative stress
(10 mM H2O2), the LAMP2-deﬁcient neurons exhibited a signiﬁcant
reduction in viability (about 50%, Po0.001), while the normal
neurons only showed a slight reduction. On the other hand, when
exposed to strong oxidative stress (30 and 50 mM H2O2), sub-
stantial cell death (over 90%) was observed in both normal and
LAMP2-deﬁcient neurons. According to some previous studies,
mild oxidative stress resulted in apoptosis while severe oxidative
stress triggered necrosis [25]. Therefore, we focused on the
apoptotic status of the iPSCs-derived neurons under a mild oxi-
dative stress condition. As revealed by TUNEL assay, the apoptotic
index in the LAMP2-deﬁcient neurons were signiﬁcantly higher
than the normal neurons (6-fold increase, Po0.001) (Fig. 2C). To
further conﬁrm the occurrence of apoptosis, we evaluated the
caspase-3/7 activities in the iPSCs-derived neurons. As showed in
Fig. 2D, the ratio of activated caspase-3/7 to MAP2-positive (cor-
tical neurons) cells was signiﬁcantly higher in the LAMP2-deﬁcient
group subjected to 10 mM H2O2 treatment although each group
exhibited a certain amount of caspase-3/7 activity. These results
suggested that the LAMP2 deﬁciency rendered the iPSCs-derived
cortical neurons more susceptible to mild oxidative stress-induced
apoptosis.
3.4. Oxidative stress-induced apoptotic cell death in LAMP2-deﬁcient
iPSCs-derived cortical neurons was mediated by cathepsin L
The association between LAMP2 deﬁciency and autophagy
impairment has been well documented. In our previous study, we
had observed abnormal accumulation of glycogen granules and
autophagosomes in the cardiac biopsy of Patient II-1 [13]. As such,
we suspected similar pathophysiological phenotype would be
observed in the iPSCs-derived neurons from Patient II-1. However,
according to the PAS staining result, we were unable to observe
any abnormal accumulation of glycogen granules in the LAMP2-
deﬁcient iPSCs-derived neurons (Fig. 3A, left panel). In the iPSCs-
derived cardiomyocytes from the same patient, aberrant glycogen
accumulation, as indicated by the deposition of deep pink stain,
was evidently observed. (Fig. 3A, right panel). In addition, we had
also examined the presence of autophagosome in the iPSCs-de-
rived cortical neurons by means of immunostaining analysis. Re-
gardless of the presence of mild oxidative stress (10 μM H2O2), no
identiﬁable accumulation of LC3-positive punctae was observed in
all sample groups (Fig. 3B). Based on this observation, we
Fig. 3. LAMP2-deﬁcient neurons showed no obvious accumulation of autophagy materials but exhibited increased levels of cytosolic cathepsin-L. (A) PAS staining revealed
no observable accumulation of glycogen granules (dark pink stain) in both normal and LAMP2-deﬁcient iPSCs-derived cortical neurons and cardiomyocytes. Scale bar: 40 μm
(B) Co-immunostaining analysis indicated that H2O2 (10 μM) treatment did not cause accumulation of LC3-positive vesicles in both normal and LAMP2-deﬁcient iPSCs-
derived cortical neurons. Scale bar: 20 μm. (C) Acridine orange staining revealed the increased leakage of acidic contents in the LAMP2-deﬁcient neurons. Scale bar: 10 μm.
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ated by LMP under the deﬁciency of LAMP2. To test this hypoth-
esis, we ﬁrst evaluated the leakage of lysosomal contents using
acridine orange staining. In the control neurons, the occurrence ofbright red punctae indicated the acidic contents were well en-
closed in intracellular compartments, such as endosomes and ly-
sosomes (Fig. 3C). On the contrary, the red ﬂuorescents were more
dispersed and no obvious punctae was noted in the LAMP2-
Fig. 4. LAMP2-deﬁcient neurons showed increase levels of cytosolic cathepsin L. (A) Western blot analysis revealed the elevated level of active cathepsin L in the LAMP2-
deﬁcient iPSCs-derived cortical neurons under non-stressed condition. (B) Western blot analysis showed that oxidative stress increased the abundance of active cathepsin L
in the cytosols. N¼3; *: Po0.05.
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released from the endosomes or lysosomes into the cytosol. In the
light of this observation, we further studied the subcellular dis-
tribution of lysosomal enzymes, particularly cathepsins, in the
cytosolic fractions of the iPSCs-derived neurons by means of
Western blotting analysis. As shown in Fig. 4A, we observed an up-
regulated production of both pro-cathepsin L (42 kDa) and active
cathepsin L (25 kDa) in the LAMP2-deﬁcient iPSCs-derived neu-
rons, but not cathepsins B or D. More speciﬁcally, the active form
of cathepsin L (25 kDa) was only detected in the cytosolic sub-
fraction of the LAMP2-deﬁcient neurons. When exposed to oxi-
dative stress, a signiﬁcant increase (1.8-fold, Po0.05) of cytosolic
cathepsin L was observed in the LAMP2-deﬁcinet neurons whilst a
relatively low level of cytosolic cathepsin L was detected in the
normal control (Fig. 4B). Taken together, these results supported
our hypothesis that the oxidative stress-induced apoptosis was
mediated by LMP under the deﬁciency of LAMP2.
3.5. Cathepsin L-speciﬁc inhibitor protected the LAMP2-deﬁcient
iPSCs-derived neurons from mild oxidative stress
In order to conﬁrm the pathological association between the
presence of cytosolic cathepsin L and oxidative stress-induced
apoptosis in the LAMP2-deﬁcient neurons, we repeated the ex-
periments with the addition of a cathepsin L speciﬁc inhibitor
(RKLLW-NH2) [26]. As shown in Fig. 5A, the application of cathe-
psin L inhibitor remarkably increased the viability of the LAMP2-
deﬁcient neurons when exposed to H2O2 (10 μM). In particular, the
application of cathepsin L inhibitor at 30 mM almost restored the
relative viability (compared with the groups without H2O2 treat-
ment) to 80% (Po0.001), and the average percentages of oxidative
stress-induced apoptotic neurons were reduced from nearly 45% to
about 4.5% (Po0.01, Fig. 5B). Similarly, the average percentages ofcaspase-3/7-activated neurons were also signiﬁcantly reduced
from about 43% to 24% (Po0.001, Fig. 5C). These results indicated
that the oxidative stress-induced apoptosis in the LAMP2-deﬁcient
neurons was mediated by cathepsin L.4. Discussion
This report is the ﬁrst to demonstrate that cortical neurons
derived from LAMP2-deﬁcient human iPSCs are more susceptible
to oxidative stress-induced apoptosis and such apoptotic cell death
is negatively regulated by cytosolic cathepsin L.
The pathological signiﬁcance of LAMP2 deﬁciency has been
well documented. According to clinical studies, the mutations in
LAMP2 genes are associated with the X-linked Danon disease. It is
now clear that Danon disease is a multisystem disorder that
characterized by severe cardiomyopathies, skeletal muscles dys-
functions, hepatic dysfunctions as well as mental retardation.
Probably due to the fact that cardiomyopathies are the leading
cause of death in Danon disease, most studies have been focused
on the cardiac manifestations while studies on the pathological
roles of LAMP2 mutations in non-cardiac tissues are very limited.
With the increasing success in cardiac transplantation operations,
those non-cardiac symptoms conversely may turn to be clinical
issues since the post-operational life of the patient is largely
affected.
In this study, we attempted to create a patient-speciﬁc iPSCs-
based model for evaluating the pathological roles of LAMP2 deﬁ-
ciency in cortical neurons, so as to provide clinical insights on
Danon disease associated mental retardation. Comparable to the
normal control, the LAMP2-deﬁcient cortical neurons appeared to
be grossly viable under non-stressed condition. However, when
they were subjected to mild levels of oxidative stress (H2O2,
Fig. 5. Cathepsin L-speciﬁc inhibitor ameliorated the oxidative stress-induced apoptosis in LAMP2-deﬁcient iPSCs-derived cortical neurons. (A) The cells of interest were
supplemented with different concentrations of cathepsin L-speciﬁc inhibitor and subjected to mild oxidative stress for 24 h, the relative cell viabilities were evaluated using
MTT Assay. The values of the groups without oxidative stress treatment were assigned as 100% viable. n¼4, ***: Po0.001 comparing to the groups treated with 10 mM H2O2
in the absence of cathepsin L-inhibitor. (B) Cathepsin L inhibitor signiﬁcantly reduced the mild oxidative stress-induced apoptosis in LAMP2-deﬁcient iPSCs-derived cortical
neurons. n¼4, ***: Po0.01. (C) LAMP2-deﬁcient iPSCs-derived cortical neurons treated 10 mM H2O2 in the presence or absence of cathepsin L inhibitor, and the percentage of
caspase-3/7 active cells were evaluated with the CellEvent Caspase-3/7 Green Detection Reagent. Scale bar: 40 mm. n¼1000 cells from 3-7 ﬁelds for each group, ***:
Po0.001.
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analyses revealed that such oxidative stress-induced cell death
was correlated with the increases in caspase-3/7 activity and
apoptotic signal.
The association between LAMP2 deﬁciency and autophagy
dysfunction has been well documented [10,27,28], meanwhile,
there is also a strong interrelationship between autophagy and
apoptosis [27,29]. As such, the oxidative stress-induced apoptosisin the LAMP2-deﬁcient neurons could be a result of autophagy
impairment. In fact, we had previously demonstrated the abnor-
mal accumulation of glycogen granules and autophagic materials
in the cardiac biopsy of the same patient (Patient II-1) [13]. In this
study, increased glycogen accumulation was again observed in the
LAMP2-deﬁcient cardiomyocytes of the same patient. However, to
our surprise, no aberrant accumulation of glycogens or LC3-posi-
tive vesicles was obtained in the LAMP2-deﬁcient iPSC-derived
C.-Y. Law et al. / Biochemistry and Biophysics Reports 5 (2016) 335–345344neurons of this patient. The exact reason for this observation re-
mains to be elucidated, but we speculated that it may be due to
the different metabolic activities in cardiomyocytes and neurons.
When the cells were treated with H2O2 (10 mM), a trace amount
of active cathepsin L became detectable in the cytosols of normal
controls; however, the levels of cytosolic active cathepsin L were
increased by almost 2 folds in the LAMP2-deﬁcient neurons. The
excessive generation of reactive oxygen species is known to cause
lipid peroxidation and lead to the damage of lysosomal membrane
[30]; however, healthy cells and tissues are usually able to combat
mild oxidative stress in the presence of intrinsic antioxidant de-
fense mechanisms [31]. Nevertheless, in the absence of LAMP2, the
lysosomal membrane integrity is plausibly reduced and becomes
more susceptible to oxidative stress thus leading to lysosomal
leakage. For example, oncogene-induced down-regulation of
LAMP1 and LAMP2 was found to increase lysosomal membrane
permeability and sensitize the lysosomal cell death pathway [32].
Although both lysosomal acid hydrolase and lysosomal cathe-
psins may contribute to lysosomal cell death, results from various
study suggest that cathepsins are the major carriers of lysosomal
cell death pathway many [33]. For example, in a rat model, ap-
plication of cathepsin inhibitors was shown to reduce neuronal
damage-induced ischemic insults [34]. Similar to this ﬁnding, our
result also demonstrated that the application of cathepsin L-spe-
ciﬁc inhibitor signiﬁcantly reduced the apoptosis in the LAMP2-
deﬁcient neurons treated with H2O2 (10 mM). This clearly de-
monstrated that cathepsin L is a key mediator of mild oxidative
stress-induced apoptosis in the LAMP2-deﬁcient neurons. Con-
versely, the transient increase of intra-lysosomal cathepsin L ac-
tivity has also been implicated in the neuronal death induced by
serum and potassium deprivation [35]. Nevertheless, the LAMP2-
deﬁcient neurons showed certain degree of lysosomal leakage
even in the absence of oxidative stress. In this regard, we suggest
that the differential susceptibility between the normal and
LAMP2-deﬁcient neurons to oxidative stress is likely due to the
increased release of lysosomal cathepsin L into the cytosol.
In summary, our study provided an important evidence for the
involvement of LMP in the oxidative stress-induced neuronal cell
death associated with LAMP2 deﬁciency. In the past decades, au-
tophagy dysfunction was suggested to be the major pathological
pathway associated with Danon disease. In the aspect of diagnosis,
the excessive accumulation of autophagic vesicles and glycogen
granules are relatively easy to identify; nevertheless, how the ac-
cumulation of these materials directly causes cell death remains
unclear. In this regard, our results provided a concrete evidence for
the presence of a non-autophagy mechanism that may help to
explain the direct effects of LAMP2 deﬁciency on the neuronal
susceptibility to oxidative stress.
In this study, we have been focused on the cortical neuron
models, however, increasing evidences have pointed out the im-
provement of cathepsin L in the progression of myopathy. Thus, it
would also be interesting to evaluate the involvement of the ly-
sosomal cell death pathway in the cardiomyocytes derived from
the LAMP2-deﬁcient iPSCs, and we are currently setting a pilot
work on such study.Funding
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